Mercy Hospital St. Louis | ClinicalTrials HQ

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)	Adnexal Diseases, DNA Virus Infections, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Infections, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, fallopian tube cancer, fallopian tube disorder, fallopian tube neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, milker's nodule, neoplasm, ovarian cancer, ovarian disorder, primary peritoneal carcinoma, vaccinia, viral infectious disease	Recruiting	Phase 3	2026-08-26		NCT05281471
The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry	Cesarean Delivery; General Anesthesia	Recruiting	Not stated	2026-06-04		NCT06030063
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery	Arrhythmias, Cardiac, Hemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, intracerebral hemorrhage, nervous system disorder, vascular disorder	Recruiting	Phase 3	2026-05-08		NCT03907046
Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial	brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder	Active, not recruiting	Not applicable	2026-03-24		NCT05478304